Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelioma, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00386815
What this trial is testing

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Eli Lilly and Company 20
Large-scale testing (Phase 3)Study completedNCT00004920
What this trial is testing

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 256
Early research (Phase 1)Study completedNCT04525859
What this trial is testing

Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Oncovir, Inc. 19
Not applicableUnknownNCT00253409
What this trial is testing

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
Institute of Cancer Research, United Kingdom 670
Testing effectiveness (Phase 2)Study completedNCT02662504
What this trial is testing

Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Lille 6
Early research (Phase 1)Study completedNCT02141347
What this trial is testing

Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma

Who this might be right for
Part A and B: Advanced Solid MalignanciesPart C: Malignant Mesothelioma
AstraZeneca 65
Testing effectiveness (Phase 2)Study completedNCT02151448
What this trial is testing

ΑDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

Who this might be right for
Malignant Neoplasm of Pancreas Metastatic to Peritoneal SurfaceMalignant Peritoneal MesotheliomaPeritoneal Carcinomatosis
David Bartlett 64
Early research (Phase 1)UnknownNCT06256055
What this trial is testing

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Malignant MesotheliomaColorectal CancerBile Duct Cancer+4 more
UTC Therapeutics Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT00597116
What this trial is testing

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Who this might be right for
Mesothelioma
Genzyme, a Sanofi Company 25
Early research (Phase 1)Study completedNCT00703638
What this trial is testing

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 16
Testing effectiveness (Phase 2)Study completedNCT00272558
What this trial is testing

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Rigshospitalet, Denmark 40
Testing effectiveness (Phase 2)Study completedNCT03207347
What this trial is testing

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Who this might be right for
MesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more
University of Florida 37
Not applicableEnrolling By InvitationNCT06885424
What this trial is testing

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Who this might be right for
Solid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more
A2 Biotherapeutics Inc. 400
Early research (Phase 1)Study completedNCT01134146
What this trial is testing

Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Lung CancerMesothelioma
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT03834272
What this trial is testing

Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies

Who this might be right for
Peritoneal Metastases
Lumicell, Inc. 18
Testing effectiveness (Phase 2)Ended earlyNCT01624090
What this trial is testing

Mithramycin for Lung, Esophagus, and Other Chest Cancers

Who this might be right for
Lung CancerEsophageal CancerMesothelioma+2 more
National Cancer Institute (NCI) 16
Not applicableActive Not RecruitingNCT03269227
What this trial is testing

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 30
Early research (Phase 1)Ended earlyNCT04173338
What this trial is testing

Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma

Who this might be right for
Non Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerUrothelial Carcinoma+1 more
Augusta University 9
Early research (Phase 1)Looking for participantsNCT05304208
What this trial is testing

DENdritic Cell Therapy Combined With SURgEry in Mesothelioma

Who this might be right for
Mesotheliomas Pleural
Erasmus Medical Center 16
Early research (Phase 1)Active Not RecruitingNCT04162015
What this trial is testing

Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 22
Next Page